298 Shares in Globe Life Inc. (NYSE:GL) Purchased by Riverview Trust Co

Riverview Trust Co bought a new position in shares of Globe Life Inc. (NYSE:GL) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 298 shares of the company’s stock, valued at approximately $32,000.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Globe Life by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 11,255,091 shares of the company’s stock worth $1,309,755,000 after buying an additional 425,993 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Globe Life by 7.5% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 101,607 shares of the company’s stock worth $11,824,000 after purchasing an additional 7,100 shares in the last quarter. Savant Capital LLC increased its position in shares of Globe Life by 951.5% during the second quarter. Savant Capital LLC now owns 75,214 shares of the company’s stock worth $6,189,000 after purchasing an additional 68,061 shares in the last quarter. Achmea Investment Management B.V. increased its position in shares of Globe Life by 151.4% during the second quarter. Achmea Investment Management B.V. now owns 29,684 shares of the company’s stock worth $2,443,000 after purchasing an additional 17,878 shares in the last quarter. Finally, Bessemer Group Inc. increased its position in shares of Globe Life by 308.5% during the first quarter. Bessemer Group Inc. now owns 11,827 shares of the company’s stock worth $1,377,000 after purchasing an additional 8,932 shares in the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Price Performance

GL opened at $109.72 on Friday. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.31. The firm has a market cap of $9.88 billion, a price-to-earnings ratio of 10.48 and a beta of 0.81. The stock’s 50-day moving average price is $103.87 and its 200 day moving average price is $90.90. Globe Life Inc. has a 12-month low of $38.95 and a 12-month high of $132.00.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $2.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.90 by $0.07. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.45 billion. Globe Life had a return on equity of 21.93% and a net margin of 18.47%. Globe Life’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.61 EPS. As a group, sell-side analysts expect that Globe Life Inc. will post 11.93 earnings per share for the current year.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Friday, October 4th will be issued a $0.24 dividend. The ex-dividend date of this dividend is Friday, October 4th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.87%. Globe Life’s payout ratio is currently 9.17%.

Insider Activity

In other Globe Life news, Director Mary E. Thigpen acquired 3,000 shares of the stock in a transaction dated Friday, July 26th. The stock was acquired at an average price of $90.20 per share, with a total value of $270,600.00. Following the completion of the transaction, the director now directly owns 15,605 shares in the company, valued at approximately $1,407,571. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.51% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on GL. Morgan Stanley upped their target price on Globe Life from $66.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. TD Cowen started coverage on Globe Life in a report on Wednesday, October 9th. They set a “buy” rating and a $150.00 price target for the company. Wells Fargo & Company increased their price target on Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Jefferies Financial Group increased their price target on Globe Life from $85.00 to $88.00 and gave the stock a “hold” rating in a report on Friday, June 28th. Finally, Raymond James increased their price target on Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a report on Tuesday. Five research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Globe Life currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.40.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.